High-Protein Nutrition for Heart Failure-related Muscle Wasting
(ASTRID-HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether high-protein nutrition can prevent muscle wasting in people with heart failure, specifically those with reduced ejection fraction. Participants will be divided into three groups: one with no protein supplement, one with a low dose, and one with a high dose of Ensure Max Protein products. The goal is to determine if increased protein intake improves muscle mass in the arms and legs. The trial seeks individuals with heart failure who have experienced frequent hospitalizations or significant weight loss in the past year. As an unphased trial, it offers a unique opportunity to contribute to understanding the potential benefits of high-protein nutrition for heart failure patients.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you must be on guideline-directed medical therapy unless it's contraindicated or not tolerated.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that high-protein diets, such as those including Ensure Max Protein, are generally safe for people with heart failure. Studies indicate that increasing protein intake to about 1.5 grams per kilogram of body weight daily does not harm the kidneys in these patients. As a result, high-protein supplements are well-tolerated and may help prevent muscle loss.
Ensure Max Protein is designed to help build muscle, which is crucial for people with heart failure who often experience muscle loss. There have been no major reports of negative effects from using this type of protein supplement in people with heart failure, making it a promising option for those wanting to maintain muscle mass.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they focus on nutritional supplementation to address muscle wasting in heart failure patients, an area not typically emphasized by standard medications like ACE inhibitors or beta-blockers. Ensure Max Protein and Ensure Original differ in their protein content, providing 30 grams and 9 grams of protein per day, respectively, which could directly support muscle maintenance and growth. This approach is novel as it targets muscle wasting through dietary intervention rather than pharmacological means, offering a potentially safer and more accessible option for improving patient outcomes.
What evidence suggests that this trial's treatments could be effective for heart failure-related muscle wasting?
Research has shown that high-protein diets can help people with heart failure improve muscle mass and strength. In this trial, participants in the experimental arm will receive Ensure Max Protein, which studies have found boosts muscle protein, crucial for those who often lose muscle. This supplement may lead to small but meaningful improvements in muscle function. Participants in the sham comparator arm will receive Ensure Original, which offers lower protein supplementation. The protein in Ensure Max Protein could help prevent muscle loss by supporting muscle rebuilding. Overall, protein supplements may offer a promising way to address muscle loss in heart failure patients.12367
Are You a Good Fit for This Trial?
This trial is for adults aged 18-100 with heart failure and reduced ejection fraction (HFrEF), experiencing muscle wasting. They must be on standard heart failure treatments, have a left ventricular ejection fraction ≤40%, and show signs of severe heart failure like hospitalizations or significant weight loss. Excluded are pregnant women, those with certain muscle disorders, severe kidney issues, allergies to milk/protein/lactose intolerance/galactosemia, or very high body weight/BMI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary protein supplementation with Ensure products, randomized between no, low, or high-dose groups
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ensure Max Protein
- Ensure Original
Ensure Max Protein is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tufts Medical Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator